1990MO Sacituzumab govitecan (SG) as second-line (2L) treatment for extensive stage small cell lung cancer (ES-SCLC): Preliminary results from the phase II TROPiCS-03 basket trial

Afshin Dowlati, Andrés Cervantes, S. Babu, Erika Hamilton, F. Susan Wong, Andrea Tazbirkova, Ivana Sullivan, C. Van Marcke de Lummen, Antoîne Italiano, Jyoti D. Patel, Sabeen Mekan, Tzu‐Ching Wu, Anne C. Chiang